Method for synthesizing DNA
    64.
    发明授权
    Method for synthesizing DNA 有权
    DNA合成方法

    公开(公告)号:US08367328B2

    公开(公告)日:2013-02-05

    申请号:US12285866

    申请日:2008-10-15

    摘要: A DNA synthesis reaction-enhancer comprising at least one kind selected from the group consisting of acidic substances and cationic complexes; a DNA synthesis method in which during a DNA synthesis reaction a reaction is carried out in the presence of the above enhancer by using DNA polymerase; a DNA synthesis reaction composition comprising the above enhancer; a DNA synthesis reaction composition comprising two or more kinds of DNA polymerases each having 3′→5′ exonuclease activity; a DNA synthesis method in which during a DNA synthesis reaction two or more kinds of DNA polymerases each having 3′→5′ exonuclease activity are used; a kit for use in in vitro DNA synthesis, comprising two or more kinds of DNA polymerases each having 3′→5′ exonuclease activity; and a kit for use in in vitro DNA synthesis, wherein the kit comprises the DNA synthesis reaction-enhancer and DNA polymerase. According to the present invention, DNA synthesis can be carried out at an efficiency more excellent as compared to conventional DNA synthesis reaction.

    摘要翻译: 一种DNA合成反应增强剂,其包含选自酸性物质和阳离子配合物中的至少一种; DNA合成方法,其中在DNA合成反应中,通过使用DNA聚合酶在上述增强剂的存在下进行反应; 包含上述增强剂的DNA合成反应组合物; 包含两种以上各自具有3'→5'核酸外切酶活性的DNA聚合酶的DNA合成反应组合物; 一种DNA合成方法,其中在DNA合成反应中使用两种或更多种具有3'→5'核酸外切酶活性的DNA聚合酶; 用于体外DNA合成的试剂盒,其包含两种或更多种各自具有3'→5'核酸外切酶活性的DNA聚合酶; 以及用于体外DNA合成的试剂盒,其中试剂盒包含DNA合成反应增强剂和DNA聚合酶。 根据本发明,与常规DNA合成反应相比,可以以更优异的效果进行DNA合成。

    METHOD FOR ENHANCING A FUNCTION OF A T CELL
    65.
    发明申请
    METHOD FOR ENHANCING A FUNCTION OF A T CELL 有权
    增强细胞功能的方法

    公开(公告)号:US20110318839A1

    公开(公告)日:2011-12-29

    申请号:US13254602

    申请日:2010-03-05

    IPC分类号: C12N5/0783

    摘要: Disclosed is a method for enhancing the function of a T cell, which is characterized by inhibiting the expression of programmed death-1 ligand 1 (PD-L1) and/or programmed death-1 ligand 2 (PD-L2) in the T cell. Also disclosed is a function-enhanced T cell which is produced by the function enhancement method. Further disclosed is a therapeutic agent comprising the function-enhanced T cell. The T cell can enhance an immune response to cancer, and is useful in an immunotherapy effective for cancer and the treatment or prevention of infectious diseases and autoimmune diseases.

    摘要翻译: 公开了一种增强T细胞功能的方法,其特征在于抑制T细胞中程序性死亡-1配体1(PD-L1)和/或程序性死亡-1配体2(PD-L2)的表达 。 还公开了通过功能增强方法产生的功能增强T细胞。 还公开了包含功能增强T细胞的治疗剂。 T细胞可以增强对癌症的免疫应答,并且可用于对癌症有效的免疫治疗和治疗或预防感染性疾病和自身免疫性疾病。